{"time":19647,"apiVersion":"v1","queryOptions":{"metadata":true,"limit":-1,"skip":-1,"count":false},"response":[{"time":0,"dbTime":2,"numResults":1,"numTotalResults":1,"resultType":"uk.ac.ebi.eva.lib.models.VariantStudy","result":[{"name":"Determinants of survival in HER2+ metastatic esophagogastric cancer.","id":"PRJEB63072","description":"This cohort contains serial WES alterations from patient samples collected as part of NCT02954536, a phase 2 evaluation of chemotherapy with trastuzumab and pembrolizumab in advanced/unresectable or metastatic esophagogastric cancer.","taxonomyId":[9606],"speciesCommonName":"Human","speciesScientificName":"Homo sapiens","sourceType":"Germline","center":"Memorial Sloan Kettering Cancer Center","material":"DNA","scope":"multi-isolate","type":"CONTROL","experimentType":"Exome Sequencing","experimentTypeAbbreviation":"ES","assembly":"-","assemblyAccession":"GCA_000001405.14","platform":"Illumina HiSeq 4000","url":"-","publications":["-"],"numVariants":0,"numSamples":99,"browsable":true,"typeName":"Control Set"}]}]}